secwatch / observer
RVRC Revium Rx.
CIK 0001839140 2 ready 8-Ks latest June 1, 2026, 9:58 AM ET RSS · JSON
Ready 8-Ks 2
Latest filing June 1, 2026, 9:58 AM ET
Top materiality 0.60
Event mix leadership ×2
Sentiment 0 pos · 0 neg · 2 neu
Executive change recent →

Recent 8-K filings for RVRC

Highest-materiality recent filing

Revium Rx CFO Arie Gordashnikov resigns; Igor Bluvstein appointed effective May 27, 2026

June 1, 2026, 9:58 AM ET leadership materiality 0.60 neutral item 5.02

Read filing →

Executive changes

Appointed

Igor Bluvstein

Chief Financial Officer
RVRC · Revium Rx.
Effective
2026-05-27
Filed
June 1, 2026, 9:58 AM ET
On May 27, 2026, our Board of Directors appointed Mr. Igor Bluvstein to serve as the Chief Financial Officer of the Company and of its subsidiaries, effective immediately.
Departed

Arie Gordashnikov

Chief Financial Officer
RVRC · Revium Rx.
Effective
2026-05-27
Successor
Igor Bluvstein
Filed
June 1, 2026, 9:58 AM ET
On May 27, 2026, Mr. Arie Gordashnikov resigned from his position as Chief Financial Officer of Revium Rx.

Materiality & sentiment trend

Max materiality 0.60 · Median 0.57 · Most common event leadership

0 positive 0 negative 2 neutral

source · RVRC on sec.gov